ACOG
Price
$5.81
Change
-$0.42 (-6.74%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
134.15M
Intraday BUY SELL Signals
SLXN
Price
$2.47
Change
-$0.10 (-3.89%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
8.04M
Intraday BUY SELL Signals
Interact to see
Advertisement

ACOG vs SLXN

Header iconACOG vs SLXN Comparison
Open Charts ACOG vs SLXNBanner chart's image
Alpha Cognition
Price$5.81
Change-$0.42 (-6.74%)
Volume$1.11K
Capitalization134.15M
Silexion Therapeutics
Price$2.47
Change-$0.10 (-3.89%)
Volume$322
Capitalization8.04M
ACOG vs SLXN Comparison Chart in %
ACOG
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACOG vs. SLXN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACOG is a Hold and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ACOG: $6.17 vs. SLXN: $2.57)
Brand notoriety: ACOG and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACOG: 138% vs. SLXN: 12%
Market capitalization -- ACOG: $134.15M vs. SLXN: $8.04M
ACOG [@Biotechnology] is valued at $134.15M. SLXN’s [@Biotechnology] market capitalization is $8.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACOG’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • ACOG’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLXN is a better buy in the long-term than ACOG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACOG’s TA Score shows that 6 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ACOG’s TA Score: 6 bullish, 3 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ACOG is a better buy in the short-term than SLXN.

Price Growth

ACOG (@Biotechnology) experienced а +0.82% price change this week, while SLXN (@Biotechnology) price change was -8.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.80%.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACOG($134M) has a higher market cap than SLXN($8.04M). ACOG YTD gains are higher at: 4.754 vs. SLXN (-91.476). SLXN has higher annual earnings (EBITDA): -17.81M vs. ACOG (-19.78M). ACOG has more cash in the bank: 39.4M vs. SLXN (3.47M). ACOG has less debt than SLXN: ACOG (2.21M) vs SLXN (3.7M). ACOG has higher revenues than SLXN: ACOG (4.59M) vs SLXN (0).
ACOGSLXNACOG / SLXN
Capitalization134M8.04M1,668%
EBITDA-19.78M-17.81M111%
Gain YTD4.754-91.476-5%
P/E RatioN/A0.01-
Revenue4.59M0-
Total Cash39.4M3.47M1,137%
Total Debt2.21M3.7M60%
TECHNICAL ANALYSIS
Technical Analysis
ACOGSLXN
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
47%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 6 days ago
29%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
36%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
48%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 8 days ago
54%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
50%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ACOG
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZH20.000.09
+0.45%
Beazer Homes USA
CELZ3.05N/A
N/A
Creative Medical Technology Holdings
GMAB30.32-0.10
-0.33%
Genmab A/S ADS
COLM51.16-0.29
-0.56%
Columbia Sportswear Company
KG14.26-0.64
-4.33%
Kestrel Group Ltd

ACOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACOG has been loosely correlated with VRCA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ACOG jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACOG
1D Price
Change %
ACOG100%
+4.58%
VRCA - ACOG
33%
Loosely correlated
+2.41%
NGNE - ACOG
30%
Poorly correlated
-5.39%
RGNX - ACOG
29%
Poorly correlated
+0.94%
PRQR - ACOG
28%
Poorly correlated
+1.71%
IMMX - ACOG
28%
Poorly correlated
+5.45%
More